Ergoteles’s Adverum Biotechnologies ADVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-8,250
Closed -$47.8K 1198
2022
Q4
$47.8K Sell
8,250
-28,618
-78% -$166K ﹤0.01% 1297
2022
Q3
$350K Sell
36,868
-5,112
-12% -$48.5K 0.01% 908
2022
Q2
$504K Buy
+41,980
New +$504K 0.02% 835
2021
Q4
Sell
-6,050
Closed -$131K 1199
2021
Q3
$131K Buy
6,050
+2,330
+63% +$50.5K ﹤0.01% 1070
2021
Q2
$130K Buy
+3,720
New +$130K ﹤0.01% 1363